Genocea Announces Poster Presentation at The European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona and Presentation at an Upcoming Investor Conference

ATLAS is Genoceas unique platform that profiles each patients T cell responses to every candidate neoantigen to select those driving pre-existing anti-tumor responses.